Betz Stephen F.

Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) · Chief Scientific Officer

Betz Stephen F. is listed in public filings as officer: Chief Scientific Officer. This Betz Stephen F. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). Investors use Betz Stephen F.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$5.2M141.3k sharesSellMar 16, 2026$236.4K6.4k shares$37.11--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$5.2M137.1k sharesSellMar 16, 2026$160.2K4.2k shares$37.77--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$2.1M47k sharesGrant / ExerciseFeb 23, 2026$2.1M47k shares$43.79--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--147.7k sharesGrant / ExerciseFeb 23, 2026Disclosure amount unavailable30k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$173k90.5k sharesGrant / ExerciseDec 26, 2025$34.4K18k shares$1.91--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.2M99.7k sharesSellJun 12, 2025$3.1M97.5k shares$32.23--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$540k58.2k sharesGrant / ExerciseJun 12, 2025$154.5K16.6k shares$9.28--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$207k108.5k sharesGrant / ExerciseJun 12, 2025$136.6K71.5k shares$1.91--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.7M108.9k sharesSellMar 19, 2025$187.2K5.5k shares$34.17--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.8M108.6k sharesSellMar 19, 2025$10.1K291 shares$34.83--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$2.4M65k sharesGrant / ExerciseFeb 20, 2025$2.4M65k shares$36.86--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--114.4k sharesGrant / ExerciseFeb 20, 2025Disclosure amount unavailable43k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$136k71.4k sharesGrant / ExerciseDec 16, 2024$4.5K2.3k shares$1.91--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.5M68.6k sharesSellSep 10, 2024$53.3K1k shares$51.50--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.7M69.6k sharesSellAug 26, 2024$159.6K3k shares$53.19--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.5M72.6k sharesSellAug 12, 2024$143.0K3k shares$47.68--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$4.0M75.6k sharesSellJul 25, 2024$160.3K3k shares$53.43--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.8M78.6k sharesSellJul 10, 2024$145.7K3k shares$48.55--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.7M80.6k sharesSellJun 25, 2024$136.1K3k shares$45.37--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$3.7M83.6k sharesSellJun 10, 2024$131.6K3k shares$43.86--